221 related articles for article (PubMed ID: 34031117)
1. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial.
Murea M; Moossavi S; Fletcher AJ; Jones DN; Sheikh HI; Russell G; Kalantar-Zadeh K
BMJ Open; 2021 May; 11(5):e047596. PubMed ID: 34031117
[TBL] [Abstract][Full Text] [Related]
2. Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.
Murea M; Patel A; Highland BR; Yang W; Fletcher AJ; Kalantar-Zadeh K; Dressler E; Russell GB
Am J Kidney Dis; 2022 Aug; 80(2):227-240.e1. PubMed ID: 34933066
[TBL] [Abstract][Full Text] [Related]
3. Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial.
Kaja Kamal RM; Farrington K; Wellsted D; Sridharan S; Alchi B; Burton J; Davenport A; Vilar E
BMJ Open; 2020 Aug; 10(8):e035919. PubMed ID: 32792431
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis.
Murea M; Highland BR; Yang W; Dressler E; Russell GB
BMC Nephrol; 2022 Sep; 23(1):322. PubMed ID: 36167537
[TBL] [Abstract][Full Text] [Related]
5. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.
Fernández Lucas M; Ruíz-Roso G; Merino JL; Sánchez R; Bouarich H; Herrero JA; Muriel A; Zamora J; Collado A
Trials; 2020 Feb; 21(1):206. PubMed ID: 32075665
[TBL] [Abstract][Full Text] [Related]
6. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.
Kalantar-Zadeh K; Unruh M; Zager PG; Kovesdy CP; Bargman JM; Chen J; Sankarasubbaiyan S; Shah G; Golper T; Sherman RA; Goldfarb DS
Am J Kidney Dis; 2014 Aug; 64(2):181-6. PubMed ID: 24840669
[TBL] [Abstract][Full Text] [Related]
7. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.
Obi Y; Streja E; Rhee CM; Ravel V; Amin AN; Cupisti A; Chen J; Mathew AT; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
Am J Kidney Dis; 2016 Aug; 68(2):256-265. PubMed ID: 26867814
[TBL] [Abstract][Full Text] [Related]
8. The role of once-weekly online hemodiafiltration with low protein diet for initiation of renal replacement therapy: A case series.
Takkavatakarn K; Kittiskulnam P; Tiranathanagul K; Katavetin P; Wongyai N; Mahatanan N; Tungsanga K; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
Int J Artif Organs; 2021 Nov; 44(11):900-905. PubMed ID: 34596447
[TBL] [Abstract][Full Text] [Related]
9. Safely reducing haemodialysis frequency during the COVID-19 pandemic.
Lodge MDS; Abeygunaratne T; Alderson H; Ali I; Brown N; Chrysochou C; Donne R; Erekosima I; Evans P; Flanagan E; Gray S; Green D; Hegarty J; Hyde A; Kalra PA; Lamerton E; Lewis D; Middleton R; New D; Nipah R; O'Donoghue D; O'Riordan E; Poulikakos D; Rainone F; Raman M; Ritchie J; Sinha S; Wood G; Tollitt J
BMC Nephrol; 2020 Dec; 21(1):532. PubMed ID: 33287730
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.
Zhang M; Wang M; Li H; Yu P; Yuan L; Hao C; Chen J; Kalantar-Zadeh K
Am J Nephrol; 2014; 40(2):140-50. PubMed ID: 25171342
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function.
Hwang HS; Hong YA; Yoon HE; Chang YK; Kim SY; Kim YO; Jin DC; Kim SH; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW
Medicine (Baltimore); 2016 Feb; 95(7):e2767. PubMed ID: 26886622
[TBL] [Abstract][Full Text] [Related]
15. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
16. Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?
Mathew AT; Obi Y; Rhee CM; Chou JA; Kalantar-Zadeh K
Semin Dial; 2018 Jul; 31(4):343-352. PubMed ID: 29737013
[TBL] [Abstract][Full Text] [Related]
17. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
18. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis.
Lin YF; Huang JW; Wu MS; Chu TS; Lin SL; Chen YM; Tsai TJ; Wu KD
Nephrology (Carlton); 2009 Feb; 14(1):59-64. PubMed ID: 19019171
[TBL] [Abstract][Full Text] [Related]
19. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
20. Initiating haemodialysis twice-weekly as part of an incremental programme may protect residual kidney function.
Kaja Kamal RM; Farrington K; Busby AD; Wellsted D; Chandna H; Mawer LJ; Sridharan S; Vilar E
Nephrol Dial Transplant; 2019 Jun; 34(6):1017-1025. PubMed ID: 30357360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
